Biomerica, Inc. (NASDAQ:BMRA – Get Free Report) saw a significant decline in short interest in December. As of December 15th, there was short interest totalling 782,800 shares, a decline of 45.3% from the November 30th total of 1,430,000 shares. Based on an average daily volume of 859,100 shares, the days-to-cover ratio is currently 0.9 days.
Institutional Investors Weigh In On Biomerica
An institutional investor recently bought a new position in Biomerica stock. Perritt Capital Management Inc acquired a new stake in shares of Biomerica, Inc. (NASDAQ:BMRA – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 70,000 shares of the company’s stock, valued at approximately $31,000. Perritt Capital Management Inc owned about 0.42% of Biomerica as of its most recent SEC filing. 22.28% of the stock is owned by institutional investors.
Biomerica Stock Down 3.0 %
Shares of NASDAQ:BMRA traded down $0.01 during midday trading on Friday, reaching $0.32. The company’s stock had a trading volume of 162,170 shares, compared to its average volume of 399,510. Biomerica has a 12-month low of $0.24 and a 12-month high of $1.35. The firm has a market capitalization of $5.31 million, a P/E ratio of -0.85 and a beta of -1.10. The firm has a 50 day moving average of $0.33 and a 200-day moving average of $0.36.
Biomerica Company Profile
Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.
Featured Stories
- Five stocks we like better than Biomerica
- Election Stocks: How Elections Affect the Stock Market
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- What Are Some of the Best Large-Cap Stocks to Buy?
- Top 3 ETFs to Hedge Against Inflation in 2025
- Canadian Penny Stocks: Can They Make You Rich?
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.